Roflumilast 500 mcg Tablets – Advanced Maintenance Therapy for Severe COPD
Cordium Pharmaceuticals is a reliable Indian pharmaceutical exporter offering high-quality Roflumilast 500 mcg Tablets for international pharmaceutical distributors, hospitals, wholesalers, and licensed importers. Roflumilast is a prescription medicine widely recommended by respiratory specialists for patients with severe Chronic Obstructive Pulmonary Disease (COPD) associated with chronic bronchitis and a history of frequent exacerbations.
Our export services are focused on regulated pharmaceutical markets including the United States, United Kingdom, United Arab Emirates, and South Africa with complete export support and professional documentation.
What is Roflumilast?
Roflumilast is an oral phosphodiesterase-4 (PDE-4) inhibitor that helps reduce inflammation inside the lungs. Unlike rescue inhalers, it is used as a long-term maintenance treatment to decrease COPD flare-ups.
It is not intended for the immediate relief of acute bronchospasm or sudden breathing attacks.
Composition
Generic Name: Roflumilast
Strength: 500 mcg (0.5 mg)
Dosage Form: Oral Tablet
Therapeutic Category: Respiratory Medicine / COPD Management
Benefits of Roflumilast Tablets
Helps reduce COPD exacerbations.
Improves long-term lung function.
Decreases airway inflammation.
Supports maintenance treatment in severe COPD.
Can be used along with prescribed bronchodilator inhalers.
Helps reduce hospitalization due to COPD flare-ups in appropriate patients.
Dosage and Administration
The recommended adult maintenance dose is one 500 mcg tablet once daily, or as prescribed by a qualified physician.
For some patients, physicians may begin with a lower dose before increasing to the maintenance dose to improve tolerability.
Patients should take the tablet at the same time every day with or without food.
Who May Benefit?
Roflumilast is prescribed for adults diagnosed with:
Severe COPD
Chronic bronchitis
Patients with repeated COPD exacerbations
Individuals receiving combination inhaler therapy requiring additional maintenance treatment
Treatment should always be initiated and monitored by a respiratory physician.
Why Respiratory Specialists Prescribe Roflumilast
Pulmonologists and respiratory physicians in developed healthcare systems frequently prescribe Roflumilast for eligible COPD patients because clinical evidence shows it can reduce exacerbation frequency when added to standard inhaled therapy.
Export Markets Served by Cordium Pharmaceuticals
United States
High prescription demand is seen in states including:
California
Texas
Florida
New York
Illinois
Pennsylvania
United Kingdom
Strong respiratory care demand from:
England
Scotland
Wales
Northern Ireland
Major prescribing centres include London, Birmingham, Manchester, Liverpool and Leeds.
United Arab Emirates
Regular pharmaceutical demand from:
Dubai
Abu Dhabi
Sharjah
Ajman
Ras Al Khaimah
South Africa
Demand is observed across:
Gauteng
Western Cape
KwaZulu-Natal
Eastern Cape
Free State
Major healthcare cities include Johannesburg, Cape Town, Durban, Pretoria and Gqeberha.
Export Availability
Cordium Pharmaceuticals supplies Roflumilast Tablets to licensed pharmaceutical importers worldwide with support for:
Private Label Manufacturing
Contract Manufacturing
Bulk Export
Hospital Supply
Pharmacy Distribution
Government & Institutional Tenders (subject to country regulations)
Export documentation support includes commercial invoice, packing list, certificate of origin and other documentation required by the destination country.
Why Choose Cordium Pharmaceuticals?
WHO-GMP manufacturing support
International export experience
Competitive pricing
Reliable packaging options
Fast shipment coordination
Dedicated export assistance
Professional customer service
Contact Cordium Pharmaceuticals
WhatsApp: +91-9405117673
Email: info@cordiumpharma.com